tirzepatide vision changes Why Your on GLP-1 Medications (And What It Means) | Dr. Dan vision issues with tirzepatide Semaglutide

High glycemic index foods, overeating, and obesity

Rapid weight loss also decreases bone density

One of the first signs of this was the weight loss reported by patients using GLP-1 drugs for their diabetes

This effect can result in postural dizziness, orthostatic hypotension, falls, and dehydration, particularly in elderly individuals, patients with kidney disease, patients on either diuretics or medications that interfere with the renin-angiotensin-aldosterone system (e.g., angiotensin-converting-enzyme inhibitors, angiotensin receptor blockers), and patients with low systolic blood pressure (138) (package insert)

Research indicates that patients who experienced weight regain after gastric bypass and subsequently received GLP-1 therapy demonstrated average additional weight loss of 10-15% of body weight over 12 months

Therefore, SR18 was incubated with trypsin (trypsin:peptide = 1:20) for 4 h, using SR4, another peptide reported earlier (Figure 10)